USFDA gives final nod to Alembic for Formoterol Fumarate inhalation solution

It also said that this ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies.

201
USFDA Approval
USFDA Approval

Last Updated on October 14, 2024 by The Health Master

Alembic Pharmaceuticals today announced that it has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial.

The approved ANDA is therapeutically equivalent to the Reference Listed Drug product (RLD), Perforomist Inhalation Solution, 20 mcg/2 ml per unit-dose vial, of Mylan Specialty, LP Formoterol Fumarate Inhalation Solution.

It is a long-acting beta2-adrenergic agonist (beta2-agonist) indicated for long-term, twice daily (morning and evening) administration.

It is used in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, the company said via a statement.

It also said that this ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies.

It further mentioned that Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial, has an estimated market size of $310 million for the twelve months ending September 2021, according to IQVIA.

USFDA grants accelerated approval for Vosoritide for injection

Zydus Cadila gets USFDA nod to market generic Cancer drug in US

Aleor Derma gets USFDA nod for Antibacterial Cream: Alembic

USFDA gives nod to Zydus Pharma for Eluxadoline Tablets

USFDA gives final nod to Zydus Cadila for Glycopyrrolate Injection

USFDA approves Drug to treat Hyperactivity disorder

World’s biggest Vegetarian Capsules plant to come in India

Fake body supplements racket busted, 3 arrested

CDSCO approves this Diabetes Tablet for use against Heart Failure

Kerala SDC urges IPEC to follow USFDA guidelines to ensure quality…

USFDA grants accelerated approval for Vosoritide for injection

Govt endorses these suggestions to amend D&C Act and DPCO

2 lakh Pharmacies in India by next year: Biddano

Drug recall: Sun Pharma recalls about 1.10 lakh bottles of Tadalafil…

CDSCO panel rejects Synokem Pharma’s application for oral Antidiabetic Drug

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news